- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 277/26 - Radicals substituted by sulfur atoms
Patent holdings for IPC class C07D 277/26
Total number of patents in this class: 94
10-year publication summary
|
4
|
7
|
3
|
9
|
5
|
8
|
8
|
3
|
3
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Red Bull GmbH | 892 |
8 |
| Bayer Pharma AG | 1048 |
4 |
| Dow AgroSciences LLC | 1217 |
4 |
| Enanta Pharmaceuticals, Inc. | 433 |
4 |
| Sanford Burnham Prebys Medical Discovery Institute | 304 |
4 |
| Merck Sharp & Dohme LLC | 3734 |
4 |
| Avexxin AS | 45 |
3 |
| The Institute of Cancer Research: Royal Cancer Hospital | 182 |
3 |
| Kumiai Chemical Industry Co., Ltd. | 312 |
3 |
| BASF SE | 21080 |
2 |
| GlycoFi, Inc. | 20 |
2 |
| Kancera AB | 30 |
2 |
| Oregon Health & Science University | 764 |
2 |
| Seoul National University Industry Foundation | 315 |
2 |
| Shin Nippon Biomedical Laboratories, Ltd. | 87 |
2 |
| Universite de droit et de La Sante de Lille 2 | 38 |
2 |
| Yale University | 2433 |
2 |
| Paris Sciences et Lettres - Quartier Latin | 217 |
2 |
| Migal Galilee Research Institute Ltd. | 57 |
2 |
| Corteva Agriscience LLC | 2702 |
2 |
| Other owners | 35 |